Ultralife (NASDAQ:ULBI) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $0.19 by 178.95 percent. This is a 314.29 percent decrease over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $47.943 million which missed the analyst consensus estimate of $55.000 million by 12.83 percent. This is a 1.27 percent decrease over sales of $48.561 million the same period last year.